OPAL - Insulin Glulisine, Diabetes Mellitus

Clinical trial NCT00272012 · COMPLETED

Trial details

NCT number: NCT00272012
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2004-07-01
Primary completion: 2006-09-01
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.